Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

NCT03025308 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2731

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Filgotinib
DRUG: Placebo to match filgotinib

Sponsor

Alfasigma S.p.A.

Collaborators

[object Object]